Growth Metrics

Microbot Medical (MBOT) Current Deferred Revenue (2011 - 2025)

Microbot Medical posted quarterly Current Deferred Revenue of $93000.0 for Q4 2025, up 452.72% on a QoQ basis from $16826.0 in Q3 2016.

Microbot Medical (MBOT) has 7 years of Current Deferred Revenue data on file, last reported at $93000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue changed N/A year-over-year to $93000.0; the trailing twelve-month figure through Dec 2025 stood at $93000.0 (changed N/A YoY), and the FY2025 full-year result was $93000.0, changed N/A from the prior year.
  • Current Deferred Revenue for Q4 2025 stood at $93000.0, up from $16826.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $93000.0 in Q4 2025 and bottomed at $93000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Microbot Medical 118.87 Mn 49.22 Mn 2,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 93,000.00
Sep 30, 2016 16,826.00
Jun 30, 2016 16,826.00
Mar 31, 2016 16,826.00
Dec 31, 2015 16,826.00
Sep 30, 2015 16,826.00
Jun 30, 2015 16,826.00
Mar 31, 2015 16,826.00
Dec 31, 2014 16,826.00
Sep 30, 2014 73,060.00
Jun 30, 2014 44,758.00
Mar 31, 2014 61,202.00
Dec 31, 2013 34,366.00
Sep 30, 2013 67,588.00
Jun 30, 2013 28,050.00
Mar 31, 2013 48,595.00
Dec 31, 2012 74,426.00
Sep 30, 2012 55,955.00
Jun 30, 2012 27,272.00
Mar 31, 2012 39,371.00
Dec 31, 2011 43,910.00
Sep 30, 2011 54,065.00
Jun 30, 2011 23,593.00